Vivoryon Therapeutics N.V. Operating Cash Flow for the year ending December 31, 2024: USD -19.85 M

Vivoryon Therapeutics N.V. Operating Cash Flow is USD -19.85 M for the year ending December 31, 2024, a -16.49% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Vivoryon Therapeutics N.V. Operating Cash Flow for the year ending December 31, 2023 was USD -23.78 M, a 1.96% change year over year.
  • Vivoryon Therapeutics N.V. Operating Cash Flow for the year ending December 31, 2022 was USD -23.32 M, a 81.97% change year over year.
  • Vivoryon Therapeutics N.V. Operating Cash Flow for the year ending December 31, 2021 was USD -12.81 M, a -25.13% change year over year.
  • Vivoryon Therapeutics N.V. Operating Cash Flow for the year ending December 31, 2020 was USD -17.12 M, a 31.40% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities